© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
Advocate for Hypertension Control and Weight Loss to Patients with Obesity, Suggest Authors of New Study
March 1st 2023
ACC 2023. Results from a 2-decade study showed that all-cause mortality rates were significantly higher in patients with obesity with uncontrolled HTN compared to those without HTN.
Lifelong Bachelor Status Significant Predictor of Death in Men, Not Women, with Heart Failure
February 28th 2023
ACC 2023. In an analysis of patients with heart failure, never having been married was associated with worse survival compared with having been married.
Insomnia Associated with Significant Risk for MI, Should be Designated a CV Risk Factor
February 28th 2023
ACC 2023. A large study found increased risk for MI regardless of age and detected particularly heightened risk among women and persons with diabetes who have insomnia.
Cognitive Behavioral Therapy Delivered via Mobile App Reduced HbA1c in Adults with Type 2 Diabetes
February 28th 2023
ACC 2023. New study found cognitive behavioral therapy delivered via mobile app significantly reduced HbA1c and need for antihyperglycemic intensification compared to use of a control app.
Frequent Cannabis Use Associated with Higher Risk of Coronary Artery Disease
February 24th 2023
ACC 2023. Daily marijuana users were 34% more likely to have coronary artery disease than never-users, according to new research.
Tezepelumab Effective in Severe Asthma Cohorts Stratified by Age at Onset, Inflammatory Phenotype, and Allergen Sensitization
February 24th 2023
AAAAI 2023. The TSLP inhibitor was superior to placebo in 2 post hoc analyses of the PATHWAY and NAVIGATOR clinical trials.
AAAAI 2023: Pediatric Asthma Risk Score Validated in Multi-cohort Study
February 23rd 2023
Future studies may consider PARS the new gold standard in predicting pediatric asthma risk, said study authors.
For Persons with Asthma Infected with COVID-19, Systemic Corticosteroid Prescribing is Up
February 23rd 2023
AAAAI 2023. Pandemic prescribing rates for systemic corticosteroids increased from Alpha to Delta to Omicron waves of COVID-19 but hospitalizations have dropped, study finds.
Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women in US, New Study Finds
November 9th 2022
AHA 2022: Study authors say more research is needed to investigate the impact of targeting social determinants of health to improve cardiometabolic risk and mortality in pregnant women.
Sotagliflozin Cuts Risk by >50% for Heart Failure Readmission, CV Death in Phase 3 SOLOIST-WHF Trial
November 9th 2022
In the SOLOIST-WHF trial, risk for HF readmission and CV death were reduced by more than 50% at 30- and 90-days after hospital discharge.